Staidson (Beijing) Biopharmaceuticals
Pre-Approval PRO BETAPipeline by Phase
Therapeutic Focus
Clinical Trials (27)
BDB-001 Phase III Trial in ANCA-Associated Vasculitis
Started: 11/10/2025
To Evaluate The Safety and Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome
Started: 10/31/2025
A Phase II Study of STSP-0902 Ophthalmic Solution in Patients With Neurotrophic Keratitis
Started: 6/12/2025
Safety and Efficacy of STSP-0601 in Adult Patients with Hemophilia a or B with Inhibitor
Started: 3/18/2024
Efficacy and Safety Study of BDB-001 in Severe COVID-19 With ALI/ARDS
Started: 7/23/2020
Safety and Efficacy of STSP-0601 in Adult Patients With Hemophilia A or B Without Inhibitor
Started: 1/9/2023
Evaluate the Safety and Efficacy of STSG-0002 Injection in Patients With Chronic Hepatitis B
Started: 4/25/2023
To Evaluate the Safety and Efficacy of STSG-0002 Injection in Patients With Chronic Hepatitis B
Started: 4/25/2023
Efficacy and Safety Study of BDB-001 Injection in Patients With Moderate to Severe Hidradenitis Suppurativa (HS)
Started: 8/18/2021
A Study to Evaluate the Safety and Tolerability of Single and Multiple Dose of STSP-0902 in Healthy Subjects
Started: 5/8/2025
A Study of STSP-0902 Ophthalmic Solution in Healthy Subjects
Started: 10/20/2024
Efficacy and Safety of Substitution of Glucocorticoid for BDB-001 Injection in Patients With Anti-neutrophil Cytoplasmic Antibody(ANCA)-Associated Vasculitis
Started: 2/22/2022
To Evaluate The Safety and Initial Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome
Started: 12/9/2023
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of STSP-0902 in Healthy Subjects
Started: 7/31/2024
A Safety and Efficacy Study of STSP-0601 in Adult Patients With Hemophilia A or B With Inhibitor
Started: 10/12/2021
A Safety Study of STSP-0601 in Adult Patients With Hemophilia A or B With Inhibitor
Started: 1/15/2020
The Safety and Tolerability of STSA-1301 Subcutaneous Injection in Healthy Subjects
Started: 11/16/2023
A Study of STSA-1002 Combined With STSA-1005 in Healthy Subjects
Started: 11/8/2022
A Safety and Tolerability Study of BDB-001 in Mild, Moderate COVID-19 Patients
Started: 2/21/2020
Safety and Efficacy Study of BDB-001 Injection in Patients With Moderate to Severe Hidradenitis Suppurativa (HS)
Started: 6/24/2021
The Safety of STSA-1002 Following Intravenous Infusion in Healthy Subjects
Started: 1/10/2022
The Safety and Tolerability of STSA-1002 Following Subcutaneous Injection in Healthy Subjects
Started: 1/31/2023
Safety and Tolerability of BDB-001 Injection in Healthy Subjects
Started: 9/25/2019
Tolerability and Safety of BDB-001 Injection in Healthy Subjects
Started: 3/12/2020
The Safety and Tolerability of STSA-1002 Following Intravenous Infusion in Healthy Subjects
Started: 9/28/2021